Sort by
Refine Your Search
-
Program
-
Employer
-
Field
-
. Empa is a research institution of the ETH Domain. The Coating Technologies Group in Empa's Laboratory for Surface Science & Coating Technologies develops next-generation functional thin-films through
-
/03/31, updated 2025/06/01, listed until 2025/07/31) Position Description: Apply Position Description The Condensed Matter Theory and Quantum Computing Group at the University of Basel led by Prof
-
11:59PM (posted 2025/06/30, listed until 2025/10/21) Position Description: Apply Position Description Mission The Chair of Representation Theory (headed by Prof. Andrei Negut) at EPFL (Lausanne
-
and collaboration within a dynamic team. This hybrid role is ideal for scientists aiming to drive impactful research while developing their own scientific identity in a highly supportive environment
-
from this research inform the development of new diagnostics, treatments, and vaccines against malaria, tuberculosis, schistosomiasis, Chagas and other neglected tropical diseases. Are you excited by
-
. Empa is a research institution of the ETH Domain. The Laboratory of Advanced Materials Processing (LAMP) is a multidisciplinary research unit that develops innovative functional modification of materials
-
. Empa is a research institution of the ETH Domain. The Urban Energy Systems Laboratory (UESL) pioneers strategies, solutions, and methods to support the development of sustainable, resilient, and
-
disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800 employees, the Department of Biomedicine is the largest
-
develop new therapies for vision loss. It is a place where your expertise will be valued, your abilities challenged, and your knowledge expanded. We are seeking qualified and highly motivated Research
-
immunoengineering. This position is part of our newly funded ERC Advanced Grant, which aims to develop genetically engineered feedback control circuits in human T cells to tackle challenging diseases. The successful